CTMX
USDCytomX Therapeutics Inc. Common Stock
$4.090+0.290 (7.632%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.800
High
$4.180
Low
$3.710
Volume
4.81M
Company Fundamentals
Market Cap
674.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
3.77M
Exchange
NMS
Currency
USD
52-Week Range
Low $0.4Current $4.090High $4.18
Related News
GlobeNewswire
CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- CX-801 (PROBODY® interferon alpha-2b) Phase 1 data demonstrate activation of tumor-selective interferon signaling in patients with advanced melanoma - - Data supportive of CX-801's mechanism of action and the
View more
Related Stocks
ZETA
Zeta Global Holdings Corp.
NASDAQ
Computer Softwa...
AVNS
Avanos Medical Inc.
NASDAQ
Industrial Spec...
AROW
Arrow Financial Corporation
NASDAQ
Major Banks
BHFAP
Brighthouse Financial Inc. Depositary Shares 6.6% Non-Cumulative Preferred Stock Series A
NASDAQ
Life Insurance
MLM
Martin Marietta Materials Inc.
NASDAQ
Mining & Quarry...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.